Orgenesis Inc (ORGS)
0.6099
-0.02
(-3.80%)
USD |
NASDAQ |
Jun 28, 16:00
0.6198
+0.01
(+1.62%)
After-Hours: 20:00
Orgenesis Cash from Investing (Quarterly): -0.068M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.068M |
| December 31, 2023 | -0.062M |
| September 30, 2023 | -0.843M |
| June 30, 2023 | -1.495M |
| March 31, 2023 | -1.307M |
| December 31, 2022 | -6.675M |
| September 30, 2022 | -2.595M |
| June 30, 2022 | -3.25M |
| March 31, 2022 | -1.613M |
| December 31, 2021 | -5.74M |
| September 30, 2021 | -5.082M |
| June 30, 2021 | -1.023M |
| March 31, 2021 | -0.539M |
| December 31, 2020 | 1.745M |
| September 30, 2020 | 1.093M |
| June 30, 2020 | -0.273M |
| March 31, 2020 | 103.04M |
| December 31, 2019 | -6.509M |
| September 30, 2019 | -3.322M |
| June 30, 2019 | -1.584M |
| March 31, 2019 | -2.363M |
| November 30, 2018 | -2.049M |
| August 31, 2018 | -1.24M |
| May 31, 2018 | -2.081M |
| February 28, 2018 | -0.898M |
| Date | Value |
|---|---|
| November 30, 2017 | -1.961M |
| August 31, 2017 | -0.541M |
| May 31, 2017 | -0.488M |
| February 28, 2017 | -0.414M |
| November 30, 2016 | -0.487M |
| August 31, 2016 | -0.341M |
| May 31, 2016 | -0.354M |
| February 29, 2016 | -0.354M |
| November 30, 2015 | -0.734M |
| August 31, 2015 | -0.254M |
| May 31, 2015 | 0.067M |
| February 28, 2015 | -0.011M |
| November 30, 2014 | 0.0087M |
| August 31, 2014 | -0.0017M |
| May 31, 2014 | -0.0039M |
| February 28, 2014 | -0.0011M |
| November 30, 2013 | -0.0008M |
| August 31, 2013 | -0.002M |
| May 31, 2013 | -0.0009M |
| February 28, 2013 | -0.0065M |
| November 30, 2012 | -0.0106M |
| August 31, 2012 | -0.0032M |
| May 31, 2012 | -0.0072M |
| February 29, 2012 | 0.00 |
| November 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-6.675M
Minimum
Dec 2022
103.04M
Maximum
Mar 2020
3.195M
Average
-1.401M
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.441M |
| Cash from Financing (Quarterly) | 3.614M |
| Free Cash Flow | -13.05M |
| Free Cash Flow Per Share (Quarterly) | -0.14 |
| Free Cash Flow to Equity (Quarterly) | -8.36M |
| Free Cash Flow to Firm (Quarterly) | -3.841M |
| Free Cash Flow Yield | -70.29% |